(Q37372180)

20 August 2017

1 reference

title

Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment (English)

1 reference

20 August 2017

Peter Humaidan

5

0 references

William Ledger

object named as

William Ledger

7

0 references

Paul Devroey

1

object named as

Paul Devroey

1 reference

20 August 2017

9

Bart C J M Fauser

1 reference

20 August 2017

Mohamed Aboulghar

2

1 reference

20 August 2017

Juan Garcia-Velasco

3

1 reference

20 August 2017

Georg Griesinger

4

1 reference

20 August 2017

Efstratios Kolibianakis

6

1 reference

20 August 2017

Candido Tomás

8

1 reference

20 August 2017

language of work or name

English

0 references

publication date

19 January 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

24

1 reference

20 August 2017

issue

4

1 reference

20 August 2017

page(s)

764-774

1 reference

Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Prospective randomized study comparing luteal phase support for ICSI patients up to the first ultrasound compared with an additional three weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Effects of vaginal progesterone administration starting on the day of oocyte retrieval on pregnancy rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

The short- and long-term implications of maternal obesity on the mother and her offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Psychological impact of infertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Why do couples refuse or discontinue ART?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

The psychological impact of mild ovarian stimulation combined with single embryo transfer compared with conventional IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

The psychological impact of IVF failure after two or more cycles of IVF with a mild versus standard treatment strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Low negative affect prior to treatment is associated with a decreased chance of live birth from a first IVF cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Manipulation of human ovarian function: physiological concepts and clinical consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Impact of overweight and underweight on assisted reproduction treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

What is the most relevant standard of success in assisted reproduction? Is BESST (birth emphasizing a successful singleton at term) truly the best?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

What is the most relevant standard of success in assisted reproduction? The next step to improving outcomes of IVF: consider the whole treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Are GnRH antagonists comparable to agonists for use in IVF?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

The concerns during assisted reproductive technologies (CART) scale and pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

A prospective study of stress among women undergoing in vitro fertilization or gamete intrafallopian transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Favourable outcomes from "mild" in-vitro fertilisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

The science behind 25 years of ovarian stimulation for in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

What is the most relevant standard of success in assisted reproduction? The singleton, term gestation, live birth rate per cycle initiated: the BESST endpoint for assisted reproduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

The ISMAAR proposal on terminology for ovarian stimulation for IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

A randomized, double-blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Coming soon to your clinic: patient-friendly ART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

What is the most relevant standard of success in assisted reproduction? Is there a single 'parameter of excellence'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

A prospective study of predictive factors of ovarian response in 'standard' IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Effect of progesterone supplementation in early pregnancy on the pregnancy outcome after in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Ovarian cyst formation following GnRH agonist administration in IVF cycles: incidence and impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Reasons for discontinuation of IVF treatment: a questionnaire study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Progesterone supplementation during early gestation after in vitro fertilization has no effect on the delivery rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Administration of progesterone before oocyte retrieval negatively affects the implantation rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

GnRH antagonists in ovarian stimulation for IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Assessment of reproductive ageing patterns by hormonal and ultrasonographic ovarian reserve tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Why do couples drop-out from IVF treatment? A prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

A longitudinal, prospective study on emotional adjustment before, during and after consecutive fertility treatment cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Women's emotional adjustment to IVF: a systematic review of 25 years of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Delaying the initiation of progesterone supplementation results in decreased pregnancy rates after in vitro fertilization: a randomized, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Does body mass index of infertile women have an impact on IVF procedure and outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

Extremes of body mass do not adversely affect the outcome of superovulation and in-vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEN468

21 January 2018

Identifiers

DOI

10.1093/HUMREP/DEN468

1 reference

release_jlekg5e3jbdejjmjbio5ueh6uq

20 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jlekg5e3jbdejjmjbio5ueh6uq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference